Researchers say a new drug-delivery implant could help patients with hard-to-treat bladder cancer avoid losing their bladders — and stay cancer-free for years.

Bladder cancer is the ninth most common cancer in the world, the fourth most common cancer in men, and the 11th most common ...

Park says patient-specific factors that influence his treatment selection include the presence of liver disease, ...

ESMO 2025 bladder cancer highlights include results from KEYNOTE-905/EV-303, RC48-C016, and IMvigor011 studies.

Bladder cancer was diagnosed through cystoscopy, with initial treatment involving surgery and Bacillus Calmette-Guérin immunotherapy. Recurrence required further surgery. Shared exposure to ...

The bladder cancer treatment landscape is rapidly evolving, particularly for patients who don’t respond to bacillus ...

Supplementing standard of care with multi-cancer testing increased diagnoses by just 2.8%, suggesting overdiagnosis is not a ...

Urothelial carcinoma is cancer of the urinary system. The urothelium is a kind of epithelial (protective) lining of the urinary system, which includes the urinary tract, bladder, your ureters (the ...